142 related articles for article (PubMed ID: 31277636)
1. Synthesized natural peptides from amphibian skin secretions increase the efficacy of a therapeutic vaccine by recruiting more T cells to the tumour site.
Pan X; Ma B; You X; Chen S; Wu J; Wang T; Walton SF; Yuan J; Wu X; Chen G; Wang Y; Ni G; Liu X
BMC Complement Altern Med; 2019 Jul; 19(1):163. PubMed ID: 31277636
[TBL] [Abstract][Full Text] [Related]
2. Comparative Proteomic Study of the Antiproliferative Activity of Frog Host-Defence Peptide Caerin 1.9 and Its Additive Effect with Caerin 1.1 on TC-1 Cells Transformed with HPV16 E6 and E7.
Ni G; Liang D; Cummins SF; Walton SF; Chen S; Wang Y; Mounsey K; Wei MQ; Yuan J; Pan X; Liu X; Wang T
Biomed Res Int; 2018; 2018():7382351. PubMed ID: 29862288
[TBL] [Abstract][Full Text] [Related]
3. Iodine-125 labeled Australian frog tree host-defense peptides caerin 1.1 and 1.9 better inhibit human breast cancer cells growth than the unlabeled peptides.
Yuan J; You X; Ni G; Wang T; Cavezza S; Pan X; Liu X
Hell J Nucl Med; 2018; 21(2):115-120. PubMed ID: 30006645
[TBL] [Abstract][Full Text] [Related]
4. Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model.
Chen S; Zhang P; Xiao L; Liu Y; Wu K; Ni G; Li H; Wang T; Wu X; Chen G; Liu X
Microbiol Spectr; 2021 Sep; 9(1):e0005121. PubMed ID: 34259550
[TBL] [Abstract][Full Text] [Related]
5. Blocking IL-10 signalling at the time of immunization renders the tumour more accessible to T cell infiltration in mice.
Chen S; Ni G; Wu X; Zhu B; Liao Z; Wang Y; Liu X
Cell Immunol; 2016 Feb; 300():9-17. PubMed ID: 26607604
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV infection by caerin 1 antimicrobial peptides.
VanCompernolle S; Smith PB; Bowie JH; Tyler MJ; Unutmaz D; Rollins-Smith LA
Peptides; 2015 Sep; 71():296-303. PubMed ID: 26026377
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
Li YL; Qiu XH; Shen C; Liu JN; Zhang J
Oncol Rep; 2010 Nov; 24(5):1323-9. PubMed ID: 20878127
[TBL] [Abstract][Full Text] [Related]
8. Topical Application of Temperature-Sensitive Gel Containing Caerin 1.1 and 1.9 Peptides on TC-1 Tumour-Bearing Mice Induced High-Level Immune Response in the Tumour Microenvironment.
Ni G; Liu X; Li H; Fogarty CE; Chen S; Zhang P; Liu Y; Wu X; Wei MQ; Chen G; Zhang P; Wang T
Front Oncol; 2021; 11():754770. PubMed ID: 34858827
[TBL] [Abstract][Full Text] [Related]
9. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
[TBL] [Abstract][Full Text] [Related]
10. IL-10 signalling blockade at the time of immunization inhibits Human papillomavirus 16 E7 transformed TC-1 tumour cells growth in mice.
Chen S; Wang X; Wu X; Wei MQ; Zhang B; Liu X; Wang Y
Cell Immunol; 2014 Jul; 290(1):145-51. PubMed ID: 24983823
[TBL] [Abstract][Full Text] [Related]
11. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules.
Smahel M; Síma P; Ludvíková V; Marinov I; Pokorná D; Vonka V
Vaccine; 2003 Mar; 21(11-12):1125-36. PubMed ID: 12559790
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC-1 tumor-bearing mice with PD-1 blockade by modulating macrophage heterogeneity and the activation of CD8
Ni G; Yang X; Li J; Wu X; Liu Y; Li H; Chen S; Fogarty CE; Frazer IH; Chen G; Liu X; Wang T
Clin Transl Immunology; 2021; 10(8):e1335. PubMed ID: 34429969
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
[TBL] [Abstract][Full Text] [Related]
14. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.
Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T
Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa.
Mechkarska M; Attoub S; Sulaiman S; Pantic J; Lukic ML; Conlon JM
Regul Pept; 2014 Nov; 194-195():69-76. PubMed ID: 25447194
[TBL] [Abstract][Full Text] [Related]
17. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
18. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
Wang QY; Xu YF; Fan DS; Peng QL; Zhang T; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):584-91. PubMed ID: 18051710
[TBL] [Abstract][Full Text] [Related]
19. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q
Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676
[TBL] [Abstract][Full Text] [Related]
20. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
Mikysková R; Indrová M; Símová J; Jandlová T; Bieblová J; Jinoch P; Bubeník J; Vonka V
Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
